EE200300269A - Fibroblasti kasvufaktorid - Google Patents
Fibroblasti kasvufaktoridInfo
- Publication number
- EE200300269A EE200300269A EEP200300269A EEP200300269A EE200300269A EE 200300269 A EE200300269 A EE 200300269A EE P200300269 A EEP200300269 A EE P200300269A EE P200300269 A EEP200300269 A EE P200300269A EE 200300269 A EE200300269 A EE 200300269A
- Authority
- EE
- Estonia
- Prior art keywords
- growth factors
- fibroblast growth
- fibroblast
- factors
- growth
- Prior art date
Links
- 102000018233 Fibroblast Growth Factor Human genes 0.000 title 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25183700P | 2000-12-08 | 2000-12-08 | |
US10/005,646 US20020151496A1 (en) | 2000-12-08 | 2001-12-07 | Novel fibroblast growth factors |
PCT/US2001/047350 WO2002046424A2 (en) | 2000-12-08 | 2001-12-10 | Fibroblast growth factors |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300269A true EE200300269A (et) | 2003-10-15 |
Family
ID=26674594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300269A EE200300269A (et) | 2000-12-08 | 2001-12-10 | Fibroblasti kasvufaktorid |
Country Status (21)
Country | Link |
---|---|
US (2) | US20020151496A1 (et) |
EP (1) | EP1389237A2 (et) |
JP (1) | JP2005506275A (et) |
KR (1) | KR20040052442A (et) |
CN (1) | CN1518597A (et) |
AU (1) | AU2603402A (et) |
BG (1) | BG107888A (et) |
BR (1) | BR0116507A (et) |
CA (1) | CA2431374A1 (et) |
CZ (1) | CZ20031570A3 (et) |
EE (1) | EE200300269A (et) |
HU (1) | HUP0400657A1 (et) |
IL (1) | IL156259A0 (et) |
MX (1) | MXPA03005142A (et) |
NO (1) | NO20032573L (et) |
PL (1) | PL366158A1 (et) |
RU (1) | RU2329058C2 (et) |
SI (1) | SI21372A (et) |
SK (1) | SK7012003A3 (et) |
WO (1) | WO2002046424A2 (et) |
ZA (1) | ZA200305236B (et) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7253266B2 (en) | 1999-07-27 | 2007-08-07 | Curagen Corporation | Polypeptides of FGF-CX |
US7189693B2 (en) | 2000-11-06 | 2007-03-13 | Curagen Corporation | Treatment of inflammatory bowel disease using fibroblast growth factor CX polypeptides |
US6982250B2 (en) | 2000-11-06 | 2006-01-03 | Curagen Corporation | Methods of prevention and treatment of inflammatory bowel disease |
CA2468610A1 (en) * | 2002-01-15 | 2003-07-24 | Eli Lilly And Company | Method for reducing morbidity and mortality in critically ill patients |
EP1608411B1 (en) | 2003-04-01 | 2010-09-29 | United States Government as represented by the Department of Veteran's Affaires | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure. |
WO2004105787A1 (en) * | 2003-05-28 | 2004-12-09 | The University Of Kyoto | Methods of using combinations of egf-2 and egf-20 to treat central nervous system disorders |
PE20141727A1 (es) | 2011-07-01 | 2014-11-26 | Ngm Biopharmaceuticals Inc | Composiciones, usos y metodos para tratamiento de trastornos y enfermedades metabolicas |
EP3798228A1 (en) | 2012-11-28 | 2021-03-31 | NGM Biopharmaceuticals, Inc. | Compositions and methods for treatment of metabolic disorders and diseases |
US9290557B2 (en) | 2012-11-28 | 2016-03-22 | Ngm Biopharmaceuticals, Inc. | Compositions comprising variants and fusions of FGF19 polypeptides |
US9273107B2 (en) | 2012-12-27 | 2016-03-01 | Ngm Biopharmaceuticals, Inc. | Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases |
AU2013370404B2 (en) | 2012-12-27 | 2017-11-02 | Ngm Biopharmaceuticals, Inc. | Methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases |
AU2014342630B2 (en) | 2013-10-28 | 2020-11-05 | Ngm Biopharmaceuticals, Inc. | Cancer models and associated methods |
CN106662577B (zh) | 2014-01-24 | 2020-07-21 | 恩格姆生物制药公司 | 结合蛋白及其使用方法 |
US10398758B2 (en) | 2014-05-28 | 2019-09-03 | Ngm Biopharmaceuticals, Inc. | Compositions comprising variants of FGF19 polypeptides and uses thereof for the treatment of hyperglycemic conditions |
US10456449B2 (en) | 2014-06-16 | 2019-10-29 | Ngm Biopharmaceuticals, Inc. | Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases |
SG11201702757YA (en) | 2014-10-23 | 2017-05-30 | Ngm Biopharmaceuticals Inc | Pharmaceutical compositions comprising peptide variants and methods of use thereof |
US10434144B2 (en) | 2014-11-07 | 2019-10-08 | Ngm Biopharmaceuticals, Inc. | Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders |
US10800843B2 (en) | 2015-07-29 | 2020-10-13 | Ngm Biopharmaceuticals, Inc. | Beta klotho-binding proteins |
ES2871036T3 (es) | 2015-11-09 | 2021-10-28 | Ngm Biopharmaceuticals Inc | Método para el tratamiento de trastornos relacionados con ácidos biliares |
US11370841B2 (en) | 2016-08-26 | 2022-06-28 | Ngm Biopharmaceuticals, Inc. | Methods of treating fibroblast growth factor 19-mediated cancers and tumors |
CN107050428B (zh) * | 2017-03-23 | 2020-05-05 | 温州医科大学 | Fgf20药物及其对脑创伤的治疗应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000060085A1 (en) * | 1999-04-02 | 2000-10-12 | Millennium Pharmaceuticals, Inc. | Fibroblast growth factor-20 |
CA2388637A1 (en) * | 1999-10-22 | 2001-05-03 | Chiron Corporation | Human fgf-20 gene and gene expression products |
AU1922101A (en) * | 1999-11-18 | 2001-05-30 | Chiron Corporation | Human fgf-21 gene and gene expression products |
WO2001092522A2 (en) * | 2000-06-01 | 2001-12-06 | Eli Lilly And Company | Human fgf-20 nucleic acids and polypeptides |
JP2004502418A (ja) * | 2000-07-03 | 2004-01-29 | キュラジェン コーポレイション | 新規の線維芽細胞増殖因子およびそれをコードする核酸 |
-
2001
- 2001-12-07 US US10/005,646 patent/US20020151496A1/en not_active Abandoned
- 2001-12-10 CN CNA018202993A patent/CN1518597A/zh active Pending
- 2001-12-10 CA CA002431374A patent/CA2431374A1/en not_active Abandoned
- 2001-12-10 WO PCT/US2001/047350 patent/WO2002046424A2/en active IP Right Grant
- 2001-12-10 MX MXPA03005142A patent/MXPA03005142A/es not_active Application Discontinuation
- 2001-12-10 EE EEP200300269A patent/EE200300269A/et unknown
- 2001-12-10 IL IL15625901A patent/IL156259A0/xx unknown
- 2001-12-10 JP JP2002548141A patent/JP2005506275A/ja active Pending
- 2001-12-10 CZ CZ20031570A patent/CZ20031570A3/cs unknown
- 2001-12-10 EP EP01995460A patent/EP1389237A2/en active Pending
- 2001-12-10 BR BR0116507-0A patent/BR0116507A/pt not_active IP Right Cessation
- 2001-12-10 AU AU2603402A patent/AU2603402A/xx active Pending
- 2001-12-10 PL PL01366158A patent/PL366158A1/xx not_active Application Discontinuation
- 2001-12-10 RU RU2003119657/14A patent/RU2329058C2/ru not_active IP Right Cessation
- 2001-12-10 HU HU0400657A patent/HUP0400657A1/hu unknown
- 2001-12-10 SI SI200120066A patent/SI21372A/sl not_active IP Right Cessation
- 2001-12-10 KR KR10-2003-7007614A patent/KR20040052442A/ko not_active Application Discontinuation
- 2001-12-10 SK SK701-2003A patent/SK7012003A3/sk unknown
-
2003
- 2003-06-06 NO NO20032573A patent/NO20032573L/no not_active Application Discontinuation
- 2003-06-06 BG BG107888A patent/BG107888A/bg unknown
- 2003-07-07 ZA ZA2003/05236A patent/ZA200305236B/en unknown
-
2007
- 2007-06-22 US US11/821,191 patent/US20080057076A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1518597A (zh) | 2004-08-04 |
CA2431374A1 (en) | 2002-06-13 |
EP1389237A2 (en) | 2004-02-18 |
US20080057076A1 (en) | 2008-03-06 |
JP2005506275A (ja) | 2005-03-03 |
BG107888A (bg) | 2004-08-31 |
SI21372A (sl) | 2004-06-30 |
CZ20031570A3 (cs) | 2004-01-14 |
HUP0400657A1 (en) | 2006-04-28 |
NO20032573D0 (no) | 2003-06-06 |
US20020151496A1 (en) | 2002-10-17 |
MXPA03005142A (es) | 2004-10-15 |
ZA200305236B (en) | 2005-06-29 |
PL366158A1 (en) | 2005-01-24 |
AU2002226034A2 (en) | 2002-06-18 |
WO2002046424A2 (en) | 2002-06-13 |
RU2329058C2 (ru) | 2008-07-20 |
AU2603402A (en) | 2002-06-18 |
IL156259A0 (en) | 2004-01-04 |
KR20040052442A (ko) | 2004-06-23 |
RU2003119657A (ru) | 2005-02-27 |
SK7012003A3 (en) | 2004-04-06 |
BR0116507A (pt) | 2004-01-06 |
NO20032573L (no) | 2003-07-22 |
WO2002046424A3 (en) | 2003-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300269A (et) | Fibroblasti kasvufaktorid | |
DK1333853T3 (da) | Vækstfaktorkompleks | |
DK1344773T3 (da) | Væksthormonsekretionsfremmere | |
NO20024890D0 (no) | Implantat | |
EE200200420A (et) | Linesoliid - kristallivorm II | |
DE60131102D1 (de) | Monofilamentband | |
AR028336A1 (es) | 4-hidroxi-tetrahidropiridonas fenilsubstituidas | |
DE60030011D1 (de) | Umpflanzungsmaschine | |
FR2806309B1 (fr) | Implant | |
AR027931A1 (es) | Antitranspirantes | |
CU23064A3 (es) | Conjunto implante dental-transportador | |
AR027982A1 (es) | Aril- y heteroarilsulfonatos | |
FR2803509B1 (fr) | Prothese metatarso-phalangienne | |
AT500246B8 (de) | Chokerring | |
FR2817889B1 (fr) | Coffrage | |
DE60133669D1 (de) | Insulinähnlichen wachstumsfaktors 1 | |
ATA19392000A (de) | Kippflügelflugzeug | |
ATA11602000A (de) | Sonnenstandsnachführungssystem | |
ATA12252000A (de) | Regensinkkasten | |
ATA21172000A (de) | Hackbrett | |
ATA17542000A (de) | Hydraulikzylinder | |
DK1217967T3 (da) | Implantat | |
DK1246934T3 (da) | Mikrobielle vækstvariationer | |
DE60140152D1 (de) | Dispergiermittel | |
ITVR20000018A1 (it) | Sgrossa pentole |